BioSpace News Archive

Organogenesis Holdings Inc. announced that company management will participate in Oppenheimer’s 32nd Annual Healthcare Conference, which is being held virtually from March 15th-16th.

CODA Biotherapeutics, Inc. today announced the appointment of Susan Catalano, Ph.D., as chief scientific officer.

Monopar Therapeutics Inc. announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will present at the 34th Annual Roth Conference and Maxim’s 2022 Virtual Growth Conference.

Women’s Brain Health Initiative and Brain Canada are pleased to announce that six exceptional research teams have been selected to receive a funding boost of $105,000 each through the Brain Canada-WBHI Expansion Grants: Considering Sex and Gender Program.

Marrone Bio Innovations, Inc. will release financial results for the fourth quarter and full year ended December 31, 2021, after market close on Monday, March 28, 2022.

INOVIO announced that Dr. J. Joseph Kim, President and CEO, will participate in a fireside chat and 1x1 investor meetings at Oppenheimer’s 32nd Annual Healthcare Conference on Tuesday, March 15, 2021.

Corbus Pharmaceuticals Holdings, Inc., an immunology company, provided corporate updates and reported financial results for the fourth quarter and year-end of 2021.

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, announced the appointment of Nancy Beesley to its Board of Directors.

PhaseBio Pharmaceuticals, Inc oday announced the completion of the bentracimab drug substance and drug product Process Performance Qualification (PPQ) campaign.

Inscopix, Inc. announced that it has launched a new application for its miniscope-based platforms to investigate neuronal activity and blood flow simultaneously, a novel research method that may prove critical to studying neurovascular dynamics in the context of aging, dementia, stroke and other debilitating diseases.